Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Charles J. Fisher"'
Autor:
Dennis E. Amundson, Usman S. Shah, Rosalia de Necochea-Campion, Michael Jacobs, Steven P. LaRosa, Charles J. Fisher
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Coronavirus−19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite advances in therapy, social distancing, masks, and vaccination many places in the world continue to see an incre
Externí odkaz:
https://doaj.org/article/421b18a21f52464f8d3aa91fb631b155
Publikováno v:
PloS one. 17(7)
The Coronavirus -19 (COVID-19) pandemic due to the SARS-CoV-2 virus has now exceeded two years in duration. The pandemic has been characterized by the development of a succession of variants containing mutations in the spike protein affecting infecti
Autor:
Michael T. Jacobs, Rosalia de Necochea-Campion, Usman S. Shah, Charles J. Fisher, Dennis E. Amundson, Steven P. LaRosa
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine
Frontiers in Medicine
Coronavirus − 19 (COVID-19) has rapidly spread throughout the world resulting in a significant amount of morbidity and mortality. Despite advances in therapy, social distancing, masks, and vaccination many places in the world continue to see an inc
Autor:
Pridvi Kandagatla, Alyson Simonds, Marcia Kuklinski, Jessica Bensenhaver, Charles J. Fisher, Lisa A. Newman, David Nathanson, Lindsay Petersen, Melissa Davis, Erica Proctor
Publikováno v:
Journal of the American College of Surgeons. 227:e78-e79
Autor:
Andrew J.H. Simpson, Sau Chi Betty Yan, Steven P. LaRosa, Jeffrey D. Helterbrand, Wipada Chaowagul, Charles J. Fisher, Nicholas J. White, Barbara G. Utterback, Steven M. Opal
Summary Background Acute septicemic melioidosis is associated with systemic release of endotoxin and the proinflammatory cytokines tumor necrosis factor (TNF)-alpha, interleukin-1, and interleukin-6. Excessive release of these cytokines may lead to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99de0d3573b58a0dabcdf90997b4550a
https://ora.ox.ac.uk/objects/uuid:6d710803-3fba-4841-9991-34a698d0d655
https://ora.ox.ac.uk/objects/uuid:6d710803-3fba-4841-9991-34a698d0d655
Autor:
Gordon D. Rubenfeld, Debra Foster, Charles J. Fisher, Deborah J. Cook, Jean Louis Vincent, Mitchell P. Fink, John C. Marshall, Eugen Faist, Konrad Reinhart
Publikováno v:
Critical Care Medicine. 31:1560-1567
Background Sepsis is not a single disease but a complex and heterogeneous process. Its expression is variable, and its severity is influenced by the nature of the infection, the genetic background of the patient, the time to clinical intervention, th
Autor:
Charles J. Fisher, Raja B. Velagapudi, Travis Ellison, Bruce Meyers, Mark A. Munger, Leah Teoh, William T. Barchuk, Steven Fischkoff, James Gallagher, Bruce Sherman
Publikováno v:
Intensive Care Medicine. 27:1169-1178
Objective: To investigate the pharmacokinetics and safety of afelimomab, a murine antibody fragment against human tumor necrosis factor (TNF)-α in patients with sepsis. Design: Multicenter, randomized, open-label, placebo-controlled phase I/II clini
Autor:
Charles J. Fisher, Wim Ruyten
Publikováno v:
AIAA Journal. 39:1587-1592
A theoretical model is described that may be used to calculate the effects of reflected light in luminescent paint measurements. The key assumption of the model is that the paint may be treated as a diffuse reflector at the paint's emission wavelengt
Autor:
Steven M. Opal, Edward Abraham, Polly E. Parsons, Michel P. Glauser, Charles A. Dinarello, Charles J. Fisher, Michael A. Matthay, John E. Repine, Jean Louis Vincent, Jonathan Cohen
Publikováno v:
Critical Care Medicine. 28:232-235
Definitions for sepsis, septic shock, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS) were developed by consensus conferences with the goal of achieving standardization of terminology and improved homogeneity of patient popula
Autor:
Rainer Brase, Robert A. Balk, John Pribble, Maire P. Shelly, John F. LaBrecque, Klaus Matzel, Steven M. Opal, Jerald C. Sadoff, Jean-François Dhainaut, Gus J. Slotman, Robert P. Baughman, James Norman, Stephen F. Lowry, Edward Abraham, Michael G. Seneff, Charles J. Fisher, Howard Dubin, Hugh Donovan, Jean Louis Vincent, Janice Lookabaugh, Eric J. DeMaria, Howard Levy
Publikováno v:
Critical Care Medicine. 25:1115-1124
Objective: To determine the therapeutic efficacy and safety of recombinant human interleukin-1 receptor antagonist (rhlL-1ra) in the treatment of patients with severe sepsis. Design: Prospective, randomized, double-blind, placebo-controlled, multicen